With the increasing use of mismatched, unrelated, and granulocyte colony-stimulating factor–
mobilized peripheral blood stem cell donor grafts and successful treatment of older …

During the last decade, the development of biomarkers for the complications seen after
allogeneic hematopoietic stem cell transplantation has expanded tremendously, with the …

Allogeneic hematopoietic stem cell transplantation is hampered by chronic graft-versus-host
disease (cGVHD), resulting in multiorgan fibrosis and diminished function. Fibrosis in lung …

BACKGROUND Chronic graft-versus-host disease (cGVHD) is a serious complication of
allogeneic hematopoietic cell transplantation (HCT). More accurate information regarding …

Chronic graft-versus-host disease (cGvHD) remains a major complication of allogeneic stem
cell transplantation requiring novel therapies. CD146 and CCR5 are expressed by activated …

Graft-versus-host disease (GVHD) remains an important cause of morbidity and mortality
after allogeneic hematopoietic cell transplantation (allo-HCT). For decades, GVHD …

Allogeneic hematopoietic cell transplantation (HCT) remains the only curative therapy for
many hematological malignant and non-malignant disorders. However, key obstacles to the …

Acute graft-versus-host disease (aGVHD) remains a major complication of allogeneic
hematopoietic cell transplantation (HCT). CD146 and CCR5 are proteins that mark activated …

Background. Chronic graft-versus-host disease (cGvHD) is a complex disorder that typically
manifests after allogeneic hematopoietic stem cell transplantation (HSCT). It is a major …

Introduction Despite significant advances in treatment and prevention, graft-versus-host
disease (GVHD) still represents the main cause of morbidity and mortality after allogeneic …